{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:42:22Z","timestamp":1790797342664,"version":"4.1.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"85","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,10,30]]},"DOI":"10.18632\/oncotarget.21216","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T06:47:21Z","timestamp":1506235641000},"page":"35517-35527","source":"Crossref","is-referenced-by-count":12,"title":["Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid"],"prefix":"10.18632","volume":"9","author":[{"given":"Pei","family":"Qiao","sequence":"first","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Le","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Xian","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jiang","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Anhalt","year":"1999","journal-title":"Lancet"},{"key":"2","first-page":"955","volume-title":"The Autoimmune Diseases, Fifth Edition","author":"Rose","year":"2014"},{"key":"3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous Pemphigoid: Physiopathology, Clinical Features and Management","volume":"23","author":"Borradori","year":"2007","journal-title":"Adv Dermatol"},{"key":"4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.iac.2012.04.002","article-title":"Clinical Features and Practical Diagnosis of Bullous Pemphigoid","volume":"32","author":"Borradori","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Diaz","year":"1995","journal-title":"J Clin Invest"},{"key":"6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Diaz","year":"2008","journal-title":"J Autoimmun"},{"key":"7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12026-008-8028-y","article-title":"Complement and cutaneous autoimmune blistering diseases","volume":"41","author":"Liu","year":"2008","journal-title":"Immunol Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Andersen","year":"2015","journal-title":"EMBO J"},{"key":"9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Remuzzi","year":"2013","journal-title":"Semin Nephrol"},{"key":"10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Ward","year":"2011","journal-title":"Cell Tissue Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Skerka","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Song","year":"2006","journal-title":"Clin Immunol"},{"key":"13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1567-5769(00)00043-6","article-title":"Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases","volume":"1","author":"Song","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2012.06.008","article-title":"The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: Review","volume":"277","author":"Xavier","year":"2012","journal-title":"Cell Immunol"},{"key":"15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1590\/S0482-50042011000500009","article-title":"Expression of complement regulatory proteins CD55, CD59, CD35, and CD46 in rheumatoid arthritis","volume":"51","author":"Xavier","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"16","first-page":"613","volume-title":"The Leucocyte Antigen FactsBook, Second Edition","author":"van der Merwe","year":"1997"},{"key":"17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Llorente","year":"2007","journal-title":"Autoimmun Rev"},{"key":"18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-2478(03)00066-X","article-title":"Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus","volume":"88","author":"Ruiz-Arg\u00fcelles","year":"2003","journal-title":"Immunol Lett"},{"key":"19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellimm.2010.07.013","article-title":"Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients","volume":"265","author":"Xavier","year":"2010","journal-title":"Cell Immunol"},{"key":"20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Llorente","year":"2006","journal-title":"Lupus"},{"key":"21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.01.003","article-title":"DAF\/CD55 and Protectin\/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis","volume":"244","author":"Xuebin","year":"2012","journal-title":"J Neuroimmunol"},{"key":"22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41598-017-00235-3","article-title":"Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/08916930600739647","article-title":"Complement regulatory proteins and autoimmunity","volume":"39","author":"Song","year":"2006","journal-title":"Autoimmunity"},{"key":"24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Zillikens","year":"2002","journal-title":"J Invest Dermatol"},{"key":"25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen","volume":"176","author":"Shimizu","year":"2010","journal-title":"Am J Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.27347","article-title":"Deletion of either CD55 or CD97 ameliorates arthritis in mouse models","volume":"62","author":"Hamann","year":"2010","journal-title":"Arthritis Rheum"},{"key":"27","first-page":"339","article-title":"Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?","volume":"144","author":"Schmidt","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0959-8049(98)00290-1","article-title":"Expression and regulation by interferon-\u03b3 of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours","volume":"35","author":"Dippold","year":"1999","journal-title":"Eur J Cancer"},{"key":"29","first-page":"167","article-title":"Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells","volume":"12","author":"Seya","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V94.5.1673","article-title":"Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition","volume":"94","author":"Haskard","year":"1999","journal-title":"Blood"},{"key":"31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.febslet.2012.01.039","article-title":"HBXIP upregulates CD46, CD55 and CD59 through ERK1\/2\/NF-\u03baB signaling to protect breast cancer cells from complement attack","volume":"586","author":"Ye","year":"2012","journal-title":"FEBS Lett"},{"key":"32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/intimm\/dxs090","article-title":"Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients","volume":"25","author":"Erdei","year":"2013","journal-title":"Int Immunol"},{"key":"33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: disease associations and therapeutic implications","volume":"46","author":"Das","year":"2009","journal-title":"Mol Immunol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Lambris","year":"2007","journal-title":"Nat Biotechnol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jid.2016.03.002","article-title":"Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion","volume":"136","author":"Wang","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:50:43Z","timestamp":1589053843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":35,"journal-issue":{"issue":"85","published-print":{"date-parts":[[2018,10,30]]}},"alternative-id":["21216","30473747"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.21216","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}